SMPV Limited supports pharmaceutical and biotech organisations with pharmacovigilance quality systems that remain inspection‑ready in practice, not just on paper.
Most organisations engage us when an inspection is announced or expected.
Inspection preparation is usually the starting point.
The focus of our work is ensuring the underlying pharmacovigilance system operates in a way that can be explained, evidenced, and defended consistently, during inspections and outside them.
Regulatory expectations for pharmacovigilance systems continue to tighten.
For many organisations, inspection readiness becomes a recurring activity rather than a stable state.
This is not usually due to lack of effort or experience.
It is more often due to systems that evolved without being clearly defined, tested, or understood as a whole from a quality perspective.
Preparing for inspections without addressing how the system actually operates often results in repeated gaps, recurring findings, and ongoing disruption.

Equip your SMEs and leadership with defensible narratives inspectors respect.

Strengthen governance, oversight, and decision‑making through sustainable processes.

Understand how your PV system actually works, not just how it appears on paper.
Strong pharmacovigilance systems are not designed for inspections as discrete events.
They are designed so that inspection activity does not alter how the system behaves.
When quality is properly integrated:
This is what inspectors assess in practice.
The Always‑Ready PV Framework replaces fragmented audits and one‑off inspection activities with a structured system for clarity, control, and continuous compliance.
The objective is not to prepare harder for inspections, but to reduce how much preparation is needed over time.
While inspections are often the trigger for engaging SMPV Limited, the framework is designed to strengthen governance, ownership, and evidence flow, so inspection readiness becomes a consequence of how the system operates day to day.
We do not deliver large remediation programmes or take ownership of operations.
We work with your existing teams and vendors to make the real system visible and defensible.
Small teams need senior clarity, not big programmes:
We do not do case processing or QPPV; we complement your vendor.
Inspection Announced or Expected?
Most teams engage SMPV when an EMA, MHRA or FDA inspection is approaching.
In these situations, the fastest and least disruptive path is to begin with Stress‑Test and then stabilise control with Strengthen.
This approach allows inspection preparation to serve a dual purpose: supporting the upcoming inspection while addressing the underlying weaknesses that tend to resurface at the next one.
Inspection preparation in this context is integrated with system improvement, ensuring that increased readiness does not disappear once inspectors leave.
Not facing an inspection?
If your goal is steady, day‑to‑day control and fewer future fire drills, start with Clarify to understand how the system currently operates and where targeted improvements will have the greatest impact.
This is often chosen by leaders who want confidence that their system would hold up to scrutiny, even without an inspection looming.

Understand how your pharmacovigilance system actually works and where accountability or evidence is unclear.
Focus areas include:
The outcome is clarity on where control genuinely sits today, rather than assumptions that only get tested
Understand how your pharmacovigilance system actually works and where accountability or evidence is unclear.
Focus areas include:
The outcome is clarity on where control genuinely sits today, rather than assumptions that only get tested during an inspection.
This phase often reveals why inspection preparation alone has not brought lasting confidence in the past.

Stabilise governance, oversight, and decision‑making so the system consistently produces inspection‑ready evidence.
This reduces reliance on informal knowledge and last‑minute coordination when inspection pressure increases.
Activities include:
Stabilise governance, oversight, and decision‑making so the system consistently produces inspection‑ready evidence.
This reduces reliance on informal knowledge and last‑minute coordination when inspection pressure increases.
Activities include:
This work supports inspection preparation while reducing the likelihood of needing the same fixes again.

Challenge the system under inspector‑style questioning.
Includes:
The aim is not rehearsed answers, but confidence that the system holds up because it is understood and controlled.
The focus is on whether the system can explain itself under challeng
Challenge the system under inspector‑style questioning.
Includes:
The aim is not rehearsed answers, but confidence that the system holds up because it is understood and controlled.
The focus is on whether the system can explain itself under challenge, not whether individuals can perform under pressure.

What changes after working with SMPV
Clients typically see:
Inspection readiness becomes a predictable outcome of how the system operates, rather than a separate exercise.
As a result, inspection preparation becomes more predictable and less disruptive, rather than a separate crisis activity.



SMPV Limited
London, United Kingdom
Copyright © 2026 SMPV Limited - All Rights Reserved.
SMPV LIMITED is a limited company registered in England and Wales.
Registered number: 11388233
Registered office: 241 Mitcham Road, Tooting, London, England, SW17 9JQ
We use strictly essential cookies. You may disable cookies, but please note that some parts of this website may become inaccessible or not function properly.
Complete the scorecard to assess your readiness and have an immediate feedback on areas to improve.
The Plug-In Strategy.
Compliance That Fits, Confidence That Lasts.